Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analysts recommend a tactical long in NIO after delivery recovery and a first quarterly profit, citing short-covering potential and a $5.00 stop.
  • Guardant Health seen as a buy after FDA companion diagnostic approval, targeting a mid-term rebound to $110 from current pullback.
  • Apogee Enterprises flagged as a value play with cost cuts and a 3%+ dividend, entry $33.33, target $42, stop $30.50.
  • Jones Act waiver did not increase domestic coastwise fuel movements; U.S. fuel exports hit a record, lifting shipping demand.
  • Broadcom will build Google's next-generation AI chips through 2031 and provide Anthropic access to ~3.5GW of capacity beginning 2027.

Latest Articles

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer
Apr 1, 2026
Leila Farooq
Press Releases

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer

Revolution Medicines has started treating patients in the global Phase 3 RASolute 303 trial evaluating daraxonrasib as monotherapy and in combination with chemotherapy for untreated metastatic pancreatic ductal adenocarcinoma (PDAC). This trial aims to improve treatment outcomes for a cancer with high unmet medical need and poor prognosis. Daraxonr…

RVMD
Orrstown Financial Services, Inc. Ranked #1 in Pennsylvania and #12 Nationally in the S&P Global Market Intelligence 2025 Ranking of Top 50 Best-Performing Community Banks
Apr 1, 2026
Avery Klein
Press Releases

Orrstown Financial Services, Inc. Ranked #1 in Pennsylvania and #12 Nationally in the S&P Global Market Intelligence 2025 Ranking of Top 50 Best-Performing Community Banks

Orrstown Financial Services, Inc., the holding company for Orrstown Bank, announced it has been ranked the top-performing community bank in Pennsylvania and 12th nationally in the S&P Global Market Intelligence 2025 rankings for banks with $3 billion to $10 billion in assets. The ranking reflects the company's strong financial performance, discipli…

ORRF
Freshworks Expands IT Asset Management Capabilities by Adding Continuous Infrastructure Discovery and Dependency Mapping to Freshservice
Apr 1, 2026
Caleb Monroe
Press Releases

Freshworks Expands IT Asset Management Capabilities by Adding Continuous Infrastructure Discovery and Dependency Mapping to Freshservice

Freshworks Inc. has upgraded its Freshservice platform by integrating continuous infrastructure discovery and dependency mapping into its IT Asset Management capabilities. The enhanced platform combines IT Service Management and IT Operations Management with a high-integrity, AI-powered Configuration Management Database (CMDB) to improve data accur…

FRSH
As AI Collides with Legacy Contact Center Technology, TTEC Digital’s Latest Software Release Is Rewriting the Enterprise AI Playbook
Apr 1, 2026
Marcus Reed
Press Releases

As AI Collides with Legacy Contact Center Technology, TTEC Digital’s Latest Software Release Is Rewriting the Enterprise AI Playbook

TTEC Digital has introduced AI Gateway, a software solution that enables enterprises to integrate modern AI capabilities with existing contact center technology without costly system overhauls. The platform supports connections with leading AI providers and CX systems, allowing clients to deploy, test, and scale AI flexibly, resulting in early repo…

TTEC
Roadzen to Present at Maxim Group’s “Powering the AI Revolution” Virtual Conference on Tuesday April 7, 2026 at 8:30am ET
Apr 1, 2026
Marcus Reed
Press Releases

Roadzen to Present at Maxim Group’s “Powering the AI Revolution” Virtual Conference on Tuesday April 7, 2026 at 8:30am ET

Roadzen Inc., a Nasdaq-listed AI company integrating insurance and mobility solutions, announced it will present at the 'Powering the AI Revolution' virtual conference hosted by Maxim Group. The presentation will highlight Roadzen’s AI-driven technology that enhances safety, reduces claims costs, and improves underwriting across international marke…

RDZN
Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy
Apr 1, 2026
Marcus Reed
Press Releases

Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy

Diginex Limited appoints Jacob Friedman as Chief Operating Officer and Sandra Kovacheva as Chief Administrative Officer to accelerate the integration of its four operating entities into a unified global platform. These leadership enhancements aim to boost operational efficiency, governance, and compliance as Diginex advances its strategy to deliver…

DGNX
TransUnion Introduces TruIQ Credit Strategy Studio to Transform How Lenders Build and Launch Prescreen Marketing Campaigns
Apr 1, 2026
Jordan Park
Press Releases

TransUnion Introduces TruIQ Credit Strategy Studio to Transform How Lenders Build and Launch Prescreen Marketing Campaigns

TransUnion introduced TruIQ Credit Strategy Studio, a self-service platform that drastically reduces prescreen campaign build times for lenders by up to 75%. The tool features no-code, drag-and-drop capabilities, real-time collaboration, and interactive dashboards, streamlining campaign development and enabling faster market responsiveness. Integra…

TRU
MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy
Apr 1, 2026
Avery Klein
Press Releases

MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy

MiNK Therapeutics disclosed that its investigational allogeneic iNKT cell therapy, agenT-797, will be featured at the ASGCT 2026 meeting. The therapy harnesses innate and adaptive immunity to target cancer, immune-mediated diseases, and severe pulmonary inflammation. The presentation underscores agenT-797's potential to modulate adaptive immune res…

INKT
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
Apr 1, 2026
Derek Hwang
Press Releases

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Context Therapeutics announced that the FDA has granted Fast Track Designation to its investigational drug CTIM-76, a CLDN6 x CD3 T cell engaging bispecific antibody, aimed at treating platinum-resistant ovarian cancer. The company is conducting a Phase 1 clinical trial with interim data expected in June 2026. This designation could expedite the de…

CNTX
Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives
Apr 1, 2026
Sofia Navarro
Press Releases

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

Plus Therapeutics, through its subsidiary CNSide Diagnostics, secured a reimbursement coverage agreement with Highmark for its CNSide CSF Tumor Cell Enumeration assay, increasing total covered lives from approximately 67 million to 75 million. This expands patient access and supports broader adoption of CNSide in the detection and monitoring of met…

PSTV
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Apr 1, 2026
Ajmal Hussain
Press Releases

Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections

Annovis Bio announced it received a U.S. patent covering the use of its investigational drug buntanetap in preventing and treating neurological injuries caused by brain infections, including those linked to Alzheimer's disease. The patent extends through 2044 and covers both preventive and therapeutic applications against a range of infectious agen…

ANVS
Cartesian Therapeutics Announces New Employment Inducement Grants
Apr 1, 2026
Leila Farooq
Press Releases

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics announced inducement stock option grants to two new employees, totaling 52,450 shares at an exercise price of $6.39 per share. The options vest over four years with a ten-year term, granted to attract talent under Nasdaq inducement rules. Cartesian is advancing its lead CAR-T therapy, Descartes-08, in clinical trials for auto…

RNAC
Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs
Apr 1, 2026
Leila Farooq
Press Releases

Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs

Adagene Inc., a clinical-stage biotech company specializing in novel antibody-based cancer immunotherapies, announced the pricing of an underwritten public offering of 18.67 million ADSs at $3.75 each, raising gross proceeds of approximately $70 million. The offering attracted participation from both new and existing institutional investors and is …

ADAG
Oportun Provides Updates on Leadership Transition
Apr 1, 2026
Avery Klein
Press Releases

Oportun Provides Updates on Leadership Transition

Oportun Financial Corporation announced that Kate Layton and Gaurav Rana will serve as interim co-CEOs following the departure of CEO Raul Vazquez. Both executives will retain their current roles while leading the company during the CEO search. Vazquez will continue as an advisor until July 2026 to facilitate a smooth transition. The board is activ…

OPRT
Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company
Apr 1, 2026
Hana Yamamoto
Press Releases

Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company

Freight Technologies announced significant progress in transforming into a software-first, AI-native logistics technology company, focusing on scaling its AI-powered platforms like Fleet Rocket, Zayren, and Fr8Radar. The company is exploring strategic alternatives for its traditional brokerage operations to concentrate resources on its AI software …

FRGT
Scorpio Tankers Inc. Announces Strategic Collaboration with AMPERA, Inc. to Develop & Commercialize Micronuclear Solutions for Global Marine and Shipping Markets
Apr 1, 2026
Derek Hwang
Press Releases

Scorpio Tankers Inc. Announces Strategic Collaboration with AMPERA, Inc. to Develop & Commercialize Micronuclear Solutions for Global Marine and Shipping Markets

Scorpio Tankers Inc. has entered into a strategic collaboration with AMPERA, Inc. to jointly develop and commercialize advanced micronuclear power solutions aimed at powering maritime vessels, offshore, and port infrastructure with zero carbon emissions. The collaboration focuses on deploying ultra-safe micro nuclear reactors, including floating nu…

STNG
Burning Rock Announces Founder’s Purchase of Its ADSs
Apr 1, 2026
Priya Menon
Press Releases

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Biotech Limited announced that founder, chairman, and CEO Yusheng Han purchased 31,487 American Depositary Shares (ADSs) for $546,603.90 on the open market, adding to prior purchases this year. These transactions signal strong insider confidence in the company's precision oncology business, which focuses on next generation sequencing (…

BNR
Acuity Reports Fiscal 2026 Second-Quarter Results
Apr 1, 2026
Priya Menon
Press Releases

Acuity Reports Fiscal 2026 Second-Quarter Results

Acuity Inc. delivered a robust second-quarter fiscal 2026 performance marked by 5% net sales growth to $1.1 billion, 21% increase in operating profit to $133 million, and a 26% rise in diluted EPS to $3.09. The company's two business segments had mixed results: Acuity Brands Lighting sales slightly declined by 2.8%, while Acuity Intelligent Spaces …

AYI